NCT00722527 Molecular Biology of Polycythemia and Thrombocytosis
| NCT ID | NCT00722527 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Polycythemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2006-07 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2006-07 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.
Eligibility Criteria
Inclusion Criteria: 1. Subjects with an elevated hemoglobin concentration (\>18 in males and \>16 in females) 2. Subjects with an elevated platelet count (\>450,000) Exclusion Criteria: 1. Subjects who have a known acquired cause of polycythemia and thrombocytosis 2. Subjects with heart disease, left to right heart shunt or severe pulmonary disease
Contact & Investigator
Josef T. Prchal, MD
PRINCIPAL INVESTIGATOR
University of Utah
Frequently Asked Questions
Who can join the NCT00722527 clinical trial?
This trial is open to participants of all sexes, studying Polycythemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00722527 currently recruiting?
Yes, NCT00722527 is actively recruiting participants. Contact the research team at josef.prchal@hsc.utah.edu for enrollment information.
Where is the NCT00722527 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT00722527 clinical trial?
NCT00722527 is sponsored by University of Utah. The principal investigator is Josef T. Prchal, MD at University of Utah. The trial plans to enroll 200 participants.